Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cyclic 11,12-erythromycin A Carbonate
2. Erythromycin A Cyclic 11,12-carbonate
1. 55224-05-0
2. Erythromycin Cyclocarbonate
3. Erythromycin A Cyclic 11,12-carbonate
4. Erythromycin A 11,12-carbonate
5. Erythromycin, Cyclic 11,12-carbonate
6. 4h3125l82r
7. Dravercin
8. (3ar,4r,7r,8s,9s,10r,11r,13r,15r,15ar)-10-(((2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4-ethyl-11-hydroxy-8-(((2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3a,7,9,11,13,15-hexamethyldecahydro-6h-[1,3]dioxolo[4,5-c][1]oxacyclotetradecine-2,6,14(7h)-trione
9. Eritromicina A Carbonato
10. Cykliczny Weglan Erytromycyny A
11. Erythromycin A Cyclic Carbonate
12. Unii-4h3125l82r
13. Carbonato Ciclico De Eritromicina A
14. Eritromicina A Carbonato [spanish]
15. Cykliczny Weglan Erytromycyny A [polish]
16. Carbonato Ciclico De Eritromicina A [spanish]
17. Chembl4788726
18. Chebi:135881
19. Dtxsid801031707
20. S7550
21. Zinc95810519
22. Akos037515854
23. Ccg-270443
24. Cs-6076
25. Ncgc00386404-01
26. Erythromycin Cyclocarbonate [who-dd]
27. Hy-100584
28. Q27259580
29. (1r,2r,5r,6s,7s,8r,9r,11r,13r,14r)-8-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-hydroxy-6-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-1,5,7,9,11,13-hexamethyl-3,15,17-trioxabicyclo[12.3.0]heptadecane-4,12,16-trione
30. (3ar,4r,7r,8s,9s,10r,11r,13r,15r,15ar)-10-(((2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4-ethyl-11-hydroxy-8-(((2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3a,7,9,11,13,15-hexamethyloctahy
31. (3ar,4r,7r,8s,9s,10r,11r,13r,15r,15ar)-10-{[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-11-hydroxy-8-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3a,7,9,11,13,15-hexamethyl-tetradecahydro-[1,3]dioxolo[4,5-c]oxacyclotetradecane-2,6,14-trione
32. 11054-95-8
1. Dravercin
2. Erythromycin A 11,12-carbonate
3. Erythromycin A Cyclic Carbonate
4. Erythromycin Cyclocarbonate
| Molecular Weight | 759.9 g/mol |
|---|---|
| Molecular Formula | C38H65NO14 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 7 |
| Exact Mass | 759.44050575 g/mol |
| Monoisotopic Mass | 759.44050575 g/mol |
| Topological Polar Surface Area | 189 Ų |
| Heavy Atom Count | 53 |
| Formal Charge | 0 |
| Complexity | 1300 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
43
PharmaCompass offers a list of Eritromicina A Carbonato API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Eritromicina A Carbonato manufacturer or Eritromicina A Carbonato supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eritromicina A Carbonato manufacturer or Eritromicina A Carbonato supplier.
PharmaCompass also assists you with knowing the Eritromicina A Carbonato API Price utilized in the formulation of products. Eritromicina A Carbonato API Price is not always fixed or binding as the Eritromicina A Carbonato Price is obtained through a variety of data sources. The Eritromicina A Carbonato Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Davercin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Davercin, including repackagers and relabelers. The FDA regulates Davercin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Davercin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Davercin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Davercin supplier is an individual or a company that provides Davercin active pharmaceutical ingredient (API) or Davercin finished formulations upon request. The Davercin suppliers may include Davercin API manufacturers, exporters, distributors and traders.
click here to find a list of Davercin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Davercin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Davercin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Davercin GMP manufacturer or Davercin GMP API supplier for your needs.
A Davercin CoA (Certificate of Analysis) is a formal document that attests to Davercin's compliance with Davercin specifications and serves as a tool for batch-level quality control.
Davercin CoA mostly includes findings from lab analyses of a specific batch. For each Davercin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Davercin may be tested according to a variety of international standards, such as European Pharmacopoeia (Davercin EP), Davercin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Davercin USP).
